Gene · 970
Papers4,349
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,621 to 1,640 of 4,349
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mogamulizumab induces long-term immune restoration and reshapes tumour heterogeneity in Sézary syndrome. | Br J Dermatol | 2022 | 35041763 | PubTator, text mining | PubMed |
| Association of Baseline and Pharmacodynamic Biomarkers With Outcomes in Patients Treated With the PD-1 Inhibitor Budigalimab. | J Immunother | 2022 | 35034046 | PubTator, text mining | PubMed |
The frequencies of peripheral blood CD5+CD19+ B cells, CD3-CD16+CD56+ NK, and CD3+CD56+ NKT cells and serum interleukin-10 in patients with multiple sclerosis and neuromyelitis optica spectrum disorder. | Allergy Asthma Clin Immunol | 2022 | 35031055 | PubTator, text mining | PubMed |
| Distinct clinical and genetic features of hepatitis B virus-associated follicular lymphoma in Chinese patients. | Blood Adv | 2022 | 35030632 | PubTator, text mining | PubMed |
| Pre-diagnostic levels of sVEGFR2, sTNFR2, sIL-2Rα and sIL-6R are associated with glioma risk: A nested case-control study of repeated samples. | Cancer Med | 2022 | 35029050 | PubTator, text mining | PubMed |
| HLA-independent T cell receptors for targeting tumors with low antigen density. | Nat Med | 2022 | 35027758 | PubTator, text mining | PubMed |
| Follicular lymphoma grade 3B and diffuse large B-cell lymphoma present a histopathological and molecular continuum lacking features of progression/ transformation. | Haematologica | 2022 | 35021600 | PubTator, text mining | PubMed |
| Novel Genetic Discoveries in Primary Immunodeficiency Disorders. | Clin Rev Allergy Immunol | 2022 | 35020168 | PubTator, text mining | PubMed |
| A comprehensive profiling of soluble immune checkpoints from the sera of patients with non-small cell lung cancer. | J Clin Lab Anal | 2022 | 35019173 | PubTator, text mining | PubMed |
| Long Non-Coding RNA Signatures Associated with Ferroptosis Predict Prognosis in Colorectal Cancer. | Int J Gen Med | 2022 | 35018112 | PubTator, text mining | PubMed |
| Where's the Beef? Understanding Allergic Responses to Red Meat in Alpha-Gal Syndrome. | J Immunol | 2022 | 35017216 | PubTator, text mining | PubMed |
| CD70 as an actionable immunotherapeutic target in recurrent glioblastoma and its microenvironment. | J Immunother Cancer | 2022 | 35017149 | PubTator, text mining | PubMed |
| A lepidic gene signature predicts patient prognosis and sensitivity to immunotherapy in lung adenocarcinoma. | Genome Med | 2022 | 35016696 | PubTator, text mining | PubMed |
| Early Reconstitution of Antibody Secreting Cells after Allogeneic Stem Cell Transplantation. | J Clin Med | 2022 | 35012014 | PubTator, text mining | PubMed |
| 3-hydroxy butyrate dehydrogenase 2 deficiency aggravates systemic lupus erythematosus progression in a mouse model by promoting CD40 ligand demethylation. | Bioengineered | 2022 | 35001849 | PubTator, text mining | PubMed |
| Comprehensive analysis of a TNF family based-signature in diffuse gliomas with regard to prognosis and immune significance. | Cell Commun Signal | 2022 | 35000592 | PubTator, text mining | PubMed |
| Identification of an at-risk subpopulation with high immune infiltration based on the peroxisome pathway and TIM3 in colorectal cancer. | BMC Cancer | 2022 | 34996408 | PubTator, text mining | PubMed |
| In vitro anti-synovial sarcoma effect of diallyl trisulfide and mRNA profiling. | Gene | 2022 | 34995734 | PubTator, text mining | PubMed |
| The CD70-CD27 axis in oncology: the new kids on the block. | J Exp Clin Cancer Res | 2022 | 34991665 | PubTator, text mining | PubMed |
| TF-Marker: a comprehensive manually curated database for transcription factors and related markers in specific cell and tissue types in human. | Nucleic Acids Res | 2022 | 34986601 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/970/papers?page=82